Health TrialsbyHealthPanel

Clinical and Radiographic Evaluation of Ridge Splitting With Simultaneous Implant Placement Covered With Concentrated Growth Factor Membranes in Narrow Alveolar Ridge

ConditionsNarrow Alveolar RidgeCGF Concentrated Growth FactorPostoperative PainImplant Placement
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-60
SponsorCairo University

About this trial

This study aims to evaluate the tissue biotype and bone density around dental implants in patients with narrow alveolar ridge. Ridge splitting with simultaneous implant placement covered with concentrated growth factor (CGF) membranes will be performed. Clinical and radiographic evaluation will be done using periodontal probe and CBCT. Pain will also be assessed using visual analogue scale (VAS) during follow-up period.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

None

Disqualifiers

Patients with systemic diseases affecting bone healing Smokers Pregnant or lactating females Patients with poor oral hygiene Patients with history of radiation therapy in the head and neck region

Trial design

Design model

Single group

Treatments tested in this trial

  • Ridge splitting

    Procedure/Surgery

    Patients with narrow alveolar ridge will undergo ridge splitting procedure using chisel to allow implant placement.

  • Dental implant placement

    Procedure/Surgery

    Intervention Description: Dental implants will be inserted simultaneously after ridge splitting in the prepared alveolar ridge.

  • Concentrated Growth Factor (CGF)

    Biological/Vaccine

    CGF membranes will be prepared from patient venous blood and placed over the grafted area to enhance healing and tissue regeneration.

Treatment groups

10 Participants
are divided into 1 treatment group
Group A: Ridge Splitting with Simultaneous Implant Placement and CGFExperimental treatment 3 interventions

Trial outcomes

Primary outcomes

1

Pain (VAS score)

Pain will be assessed using Visual Analogue Scale (VAS) ranging from 0 to 10.

Time frame
1st day and 3rd day postoperative

Secondary outcomes

1

Tissue biotype thickness

Tissue biotype will be assessed using a periodontal probe and measured in millimeters.

Time frame
Immediately postoperative and after 4 months

Other outcomes

1

Bone density

Bone density will be evaluated using CBCT and measured in Hounsfield units (HU).

Time frame
Immediately postoperative and after 4 months

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Cairo University

Lead sponsor

Source ClinicalTrials.gov

This trial is not recruiting at the moment. You can still explore other options: